Cargando…
Peripartum Cardiomyopathy: Risks Diagnosis and Management
Peripartum cardiomyopathy is a rare cause of heart failure that occurs during late pregnancy or in the early postpartum period. Delays in diagnosis may occur as symptoms of heart failure mimic those of normal pregnancy. The diagnosis should be considered in any pregnant or postpartum woman with symp...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164389/ https://www.ncbi.nlm.nih.gov/pubmed/37163197 http://dx.doi.org/10.2147/JMDH.S372747 |
_version_ | 1785038058758864896 |
---|---|
author | Carlson, Selma Schultz, Jessica Ramu, Bhavadharini Davis, Melinda B |
author_facet | Carlson, Selma Schultz, Jessica Ramu, Bhavadharini Davis, Melinda B |
author_sort | Carlson, Selma |
collection | PubMed |
description | Peripartum cardiomyopathy is a rare cause of heart failure that occurs during late pregnancy or in the early postpartum period. Delays in diagnosis may occur as symptoms of heart failure mimic those of normal pregnancy. The diagnosis should be considered in any pregnant or postpartum woman with symptoms concerning for heart failure. If there are clinical concerns, labs including N-terminal pro-BNP should be checked, and an echocardiogram should be ordered to assess for systolic dysfunction. Prompt medical treatment tailored for pregnancy and lactation is essential to prevent adverse events. Outcomes are variable, including complete recovery, persistent myocardial dysfunction with heart failure symptoms, arrhythmias, thromboembolic events, and/or rapid deterioration requiring mechanical circulatory support and cardiac transplantation. It is essential that care is provided as part of a multidisciplinary cardio-obstetrics team including obstetrics, cardiology, maternal fetal medicine, anesthesiology, and nursing. All women with peripartum cardiomyopathy should have close follow-up with a cardiologist, although optimal duration of medical therapy following complete recovery is unknown. Women considering a subsequent pregnancy require preconception counseling and close collaboration between obstetrics and cardiology throughout pregnancy. |
format | Online Article Text |
id | pubmed-10164389 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-101643892023-05-08 Peripartum Cardiomyopathy: Risks Diagnosis and Management Carlson, Selma Schultz, Jessica Ramu, Bhavadharini Davis, Melinda B J Multidiscip Healthc Review Peripartum cardiomyopathy is a rare cause of heart failure that occurs during late pregnancy or in the early postpartum period. Delays in diagnosis may occur as symptoms of heart failure mimic those of normal pregnancy. The diagnosis should be considered in any pregnant or postpartum woman with symptoms concerning for heart failure. If there are clinical concerns, labs including N-terminal pro-BNP should be checked, and an echocardiogram should be ordered to assess for systolic dysfunction. Prompt medical treatment tailored for pregnancy and lactation is essential to prevent adverse events. Outcomes are variable, including complete recovery, persistent myocardial dysfunction with heart failure symptoms, arrhythmias, thromboembolic events, and/or rapid deterioration requiring mechanical circulatory support and cardiac transplantation. It is essential that care is provided as part of a multidisciplinary cardio-obstetrics team including obstetrics, cardiology, maternal fetal medicine, anesthesiology, and nursing. All women with peripartum cardiomyopathy should have close follow-up with a cardiologist, although optimal duration of medical therapy following complete recovery is unknown. Women considering a subsequent pregnancy require preconception counseling and close collaboration between obstetrics and cardiology throughout pregnancy. Dove 2023-05-03 /pmc/articles/PMC10164389/ /pubmed/37163197 http://dx.doi.org/10.2147/JMDH.S372747 Text en © 2023 Carlson et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Carlson, Selma Schultz, Jessica Ramu, Bhavadharini Davis, Melinda B Peripartum Cardiomyopathy: Risks Diagnosis and Management |
title | Peripartum Cardiomyopathy: Risks Diagnosis and Management |
title_full | Peripartum Cardiomyopathy: Risks Diagnosis and Management |
title_fullStr | Peripartum Cardiomyopathy: Risks Diagnosis and Management |
title_full_unstemmed | Peripartum Cardiomyopathy: Risks Diagnosis and Management |
title_short | Peripartum Cardiomyopathy: Risks Diagnosis and Management |
title_sort | peripartum cardiomyopathy: risks diagnosis and management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10164389/ https://www.ncbi.nlm.nih.gov/pubmed/37163197 http://dx.doi.org/10.2147/JMDH.S372747 |
work_keys_str_mv | AT carlsonselma peripartumcardiomyopathyrisksdiagnosisandmanagement AT schultzjessica peripartumcardiomyopathyrisksdiagnosisandmanagement AT ramubhavadharini peripartumcardiomyopathyrisksdiagnosisandmanagement AT davismelindab peripartumcardiomyopathyrisksdiagnosisandmanagement |